Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AX Various alimentary tract and metabolism products
A16AX10 Eliglustat
D09894 Eliglustat tartrate (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Eliglustat
D09894 Eliglustat tartrate (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D09894 Eliglustat tartrate (JAN/USAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00148 Eliglustat
D09894 Eliglustat tartrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00148 Eliglustat
D09894 Eliglustat tartrate
Transporter substrate
DG01665 ABCB1 substrate
DG00148 Eliglustat
D09894 Eliglustat tartrate
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Hexosyltransferases
UGCG
D09894 Eliglustat tartrate (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09894
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09894
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09894
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09894
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09894
Drug transporters
D09894
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D09894
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00148 Eliglustat
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00148 Eliglustat
Transporter substrate
DG01665 ABCB1 substrate
DG00148 Eliglustat